Abstract:Endothelial cell monolayer (EM), acting as a barrier between blood and tissue, plays an important role in pathophysiological processes. Here we describe a novel microfluidic chip that is applied for convenient and high throughput in vitro permeability assays of EM. The chip included a gradient generator and an array of cell culture chambers. A microporous membrane as a scaffold component was built between a polydimethylsiloxane (PDMS) layer and a glass substrate to grow EM. Cell culture chambers were separated… Show more
“…116,117 These assays are highly quantitative and are able to produce time-dependent permeability data able to discern transient effects. Miniaturization and parallelization of these assays, both fluorescent-based macromolecule transport 118 and commercially available 96-well platforms and culture plates for measuring transendothelial electrical resistance, permit screening assays to use endothelial permeability as a direct functional output.…”
The complexity and diversity of many human diseases pose significant hurdles to the development of novel therapeutics. New scientific and technological advances, such as pharmacogenetics, provide valuable frameworks for understanding genetic predisposition to disease and tools for diagnosis and drug development. However, another framework is emerging based on recent scientific advances, one we suggest to call pharmacoempirics. Pharmacoempirics takes advantage of merging two nascent fields: first, the generation of induced pluripotent stem cells, which are differentiated into mature cell types and represent patient-specific genetic backgrounds, and, second, bioengineering advances allowing sophisticated re-creation of human pathophysiology in laboratory settings. The combination of these two innovative technologies should allow new experimentation on disease biology and drug discovery, efficacy, and toxicology unencumbered by hypothesis generation and testing. In this review, we discuss the challenges and promises of this exciting new type of discovery platform and outline its implementation for cardiovascular drug discovery.
“…116,117 These assays are highly quantitative and are able to produce time-dependent permeability data able to discern transient effects. Miniaturization and parallelization of these assays, both fluorescent-based macromolecule transport 118 and commercially available 96-well platforms and culture plates for measuring transendothelial electrical resistance, permit screening assays to use endothelial permeability as a direct functional output.…”
The complexity and diversity of many human diseases pose significant hurdles to the development of novel therapeutics. New scientific and technological advances, such as pharmacogenetics, provide valuable frameworks for understanding genetic predisposition to disease and tools for diagnosis and drug development. However, another framework is emerging based on recent scientific advances, one we suggest to call pharmacoempirics. Pharmacoempirics takes advantage of merging two nascent fields: first, the generation of induced pluripotent stem cells, which are differentiated into mature cell types and represent patient-specific genetic backgrounds, and, second, bioengineering advances allowing sophisticated re-creation of human pathophysiology in laboratory settings. The combination of these two innovative technologies should allow new experimentation on disease biology and drug discovery, efficacy, and toxicology unencumbered by hypothesis generation and testing. In this review, we discuss the challenges and promises of this exciting new type of discovery platform and outline its implementation for cardiovascular drug discovery.
“…9,10 The size of a microfluidic channel can be adjusted to that of a microvessel, and various vascular cells can be cultured in the channel under blood flow-like flow conditions. [11][12][13] In one approach, a porous membrane was integrated into a microfluidic device and utilized to evaluate the permeability of an endothelial monolayer on the membrane against fluorescein isothiocyanatelabeled bovine serum albumin (FITC-BSA) [14][15][16] and lipid-coated nanoparticles. 16 However, the pores within the monolayer are irregular in size and shape, as shown in previous studies.…”
“…Microfluidic in vitro models, which are advantageous over in vivo models because they can generate well-defined shear stress in a controllable and repeatable manner, have been used to study shear stress effects on morphology [4] and permeability [5], but no previous system has managed to simultaneously induce the full-spectrum range of shear stress and investigate effects on permeability. Microfluidic systems have induced a shear stress range with geometric variation [6], but the non-uniform shear stress applied to the cell populations make such channels unfeasible for nonimaging measurement methods.…”
We characterized the first high-throughput permeability assay platform enabling compound permeability assays, at the full spectrum (1-60dyn/cm 2 ) of shear stress, on endothelial cells. The platform comprises four parallel channels, with a porous membrane bonded between layers enabling permeability assays under four shear stresses per chip, ranging ~15x in magnitude. In the bEnd.3 brain endothelial cell line, decreased permeability was observed at rates of 4.06e -8 and 6.04e -8 cm/s per unit shear stress (dyn/cm 2 ) for FITC-Dextran and propidium iodide, respectively. Image analysis of cell stains indicated increased elongation and cell alignment with shear stress at rates of 9.15e -4 and 0.12° per dyn/cm 2 , respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.